FDA approves Zykadia for late-stage lung cancer
April 30, 2014Research and Development, Sales and Marketing Cancer, FDA, Novartis, lung, zykadia
Novartis’ ‘breakthrough’ drug Zykadia has been approved by the FDA to treat lung cancer patients with a particular genetic mutation. …
Lonza makes change at the top
April 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, funk
Swiss pharma supplier firm Lonza has confirmed a leadership change as its chief operating officer (COO) leaves. Marc Funk has …
Cancer Research funding to be doubled
April 30, 2014Research and Development, Sales and Marketing CRUK, Cancer, brain, breast, funding, lung
Cancer Research UK is to increase its research funding by 50% over the next decade as part of a new strategy …
Facebook dementia app created
April 29, 2014Medical Communications, Sales and Marketing Alzheimer's, Facebook, app, dementia
Alzheimer’s Research UK has launched a new Facebook app which allows users to see what it is like to suffer …
BMS expands Samsung deal
April 29, 2014Manufacturing and Production BMS, Roche, Samsung, UCSF, biologics, incheon
Bristol-Myers Squibb has expanded its biopharmaceutical manufacturing agreement with South Korea’s Samsung BioLogics. Last year, Bristol-Myers Squibb signed a 10-year …
‘Transformational’ NHS social media tool launches
April 29, 2014Medical Communications, Sales and Marketing NHS, digital, healthberry, king, social media
London-based startup firm HealthBerry has developed a social media web and mobile application that is set to transform how the …
Pfizer ‘significantly undervalued’ AstraZeneca
April 29, 2014Sales and Marketing AstraZeneca, Pfizer, acquisition, buyout, merger
AstraZeneca has broken its silence to insist that Pfizer’s financial offer in January for the company “very significantly undervalued AstraZeneca …
PrimeVigilance appoints chief medical officer
April 29, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing primevigilance, seebeck
Pharmacovigilance and medical services firm PrimeVigilance has appointed Dr Joerg Seebeck as its chief medical officer. Seebeck is to head …
Humira drives AbbVie again
April 28, 2014Sales and Marketing AbbVie, Abbott, Humira, RA
Rheumatoid arthritis treatment Humira has once more driven AbbVie, bringing in more than half the company’s sales in the first …
NICE chair: pharma must show how it prices drugs
April 28, 2014Research and Development, Sales and Marketing Goldacre, Haslam, NICE, VBP, all trials, pars
The pharmaceutical industry must be willing to show the public how it prices its drugs – or face losing its …
Pfizer makes second bid for AstraZeneca
April 28, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, acquisition, deal, merger
Pfizer has made a second attempt to buy AstraZeneca after an initial request was rejected in January. The biggest pharma …
Brazil focus: not just another BRIC in the wall
April 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BRIC, Brazil, emerging markets, market access, rio
Population: 198.7 million (2012) Government: Federal presidential republic Leader: President Dilma Rousseff of the centre-left Workers’ Party Gross Domestic Product: …
reViral hires non-executive director
April 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing reviral, schinazi
Antiviral drug firm reViral has appointed Professor Raymond 
Schinazi as a non-executive director. Schinazi has had a long and prestigious …
Mekinist shown green light by CHMP
April 28, 2014Sales and Marketing CHMP, Cancer, GSK, mekinist, oncology, trametinib
GlaxoSmithKline’s melanoma drug Mekinist is virtually nailed on to be given approval in the European Union following a positive opinion …
Novartis reports healthy profit
April 25, 2014Sales and Marketing Afinitor, Gleevec, Glivec, Novartis, Q1, lilly
Multiple sclerosis drug Gilenya and cancer treatment Afinitor were among the biggest sellers for Novartis, as the Swiss company’s net …
Lupin adds chief corporate development officer
April 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lupin, theresa stevens
Mumbai-based pharma firm Lupin has hired Theresa Stevens to be its chief corporate development officer. Stevens will be assuming …
NHS documentary counts cost
April 25, 2014Medical Communications, Sales and Marketing Channel 4, Drug pricing, NHS, PPRS, vba
The funding issues facing the NHS are to be explored in a new documentary series on Channel 4. Set to …
Profits slump at AstraZeneca
April 24, 2014Sales and Marketing AZD9291, AstraZeneca, BMS, Brilinta, Q1
AstraZeneca has continued its poor run of form, with operating profit in the first quarter of 2014 falling 40% on …
PPD hires Bhooshi De Silva as senior VP


April 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PPD, de silva
Contract research organisation Pharmaceutical Product Development (PPD) has added Bhooshi De Silva as senior VP of corporate development and strategy …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
